跳至主要内容
临床试验/NCT00784797
NCT00784797已完成4 期

Comparison Between Misopristol and Pitocin After Mifepristone Preparation for Second Trimeter Abortion

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 145 人开始时间: 2009年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
145
试验地点
1
主要终点
Success rate of abortion

研究概览

简要总结

Second trimester abortion can be done surgically or medically. Medical abortion with mifepristone and misopristol is one of the common protocol, but misopristol have high rate side effect. The investigators recent study proved the efficacy of pitocin after mifepristone in second trimester abortion with minimal side effects.

Working hypothesis and aims: To compare misopristol and pitocin after mifepristone preparation in second trimester in seccess rate, interval to abortion, side effects and patient satisfaction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • midtrimester late abortion
  • midtrimester induced abortion

排除标准

  • placenta previa
  • infected abortion
  • rupture of membranes
  • s/p cesarean section *2 or more

研究组 & 干预措施

pitocin

Active Comparator

high dose pitocin drip 48 hours after mifepristone preparation.

干预措施: mifepristone and oxytocin (Drug)

misopristol

Active Comparator

vaginal and oral misopristol 48 hours after mifepristone preparation.

干预措施: mifepristone and misopristol (Drug)

结局指标

主要结局

Success rate of abortion

时间窗: 24 hours

Interval to abortion

时间窗: 24 hours

次要结局

  • Side effects(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Assaf Ben Meir

MD

Hadassah Medical Organization

研究点 (1)

Loading locations...

相似试验